Home > Insider Trading > Filing (0000950170-25-036676)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1020214	Cerus Corp	CERS	Surgical & Medical Instruments & Apparatus (3841)	680262011

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1296322	J Richard Benjamin	C/O Cerus Corporation 1220 Concord Ave Suite 600 Concord CA 94520	Chief Medical Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2025-03-06	300,000	$0.00	694,373	No	4	A	Direct
Common Stock	Acquisiton	2025-03-06	66,565	$0.00	760,938	No	4	A	Direct
Common Stock	Disposition	2025-03-07	26,139	$1.50	734,799	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	A	Direct
No	4	S	Direct

Footnotes

Represents RSUs granted pursuant to the Issuer's 2024 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest in two annual installments with 34% of the grant vesting on March 12, 2026, and 66% of the grant vesting on March 12, 2027, subject to the Reporting Person's continuous service to the Issuer through such vesting date.
Represents RSUs granted pursuant to the Issuer's 2024 Equity Incentive Plan. These RSUs were granted in payment of a portion of the 2024 annual bonus awarded to the Reporting Person and were fully vested upon grant, with no expiration date.
Represents shares sold pursuant to an instruction intended to comply with the requirement of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fees in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person.
Represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.445 to $1.54 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.